Your browser doesn't support javascript.
loading
Clinical follow-up of 411 patients with relapsing and progressive multiple sclerosis 10 years after discontinuing mitoxantrone treatment: a real-life cohort study.
Chartier, N; Epstein, J; Soudant, M; Dahan, C; Michaud, M; Pittion-Vouyovitch, S; Guillemin, F; Debouverie, M; Mathey, G.
Affiliation
  • Chartier N; Department of Neurology, Nancy University Hospital, Nancy, France.
  • Epstein J; CIC-EC Inserm 1433, Vandoeuvre-Lès-Nancy, France.
  • Soudant M; Université de Lorraine, EA 4360 Apemac, Vandoeuvre-Lès-Nancy, France.
  • Dahan C; CIC-EC Inserm 1433, Vandoeuvre-Lès-Nancy, France.
  • Michaud M; Department of Neurology, Nancy University Hospital, Nancy, France.
  • Pittion-Vouyovitch S; Department of Neurology, Nancy University Hospital, Nancy, France.
  • Guillemin F; Department of Neurology, Nancy University Hospital, Nancy, France.
  • Debouverie M; CIC-EC Inserm 1433, Vandoeuvre-Lès-Nancy, France.
  • Mathey G; Université de Lorraine, EA 4360 Apemac, Vandoeuvre-Lès-Nancy, France.
Eur J Neurol ; 25(12): 1439-1445, 2018 12.
Article in En | MEDLINE | ID: mdl-29996003

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mitoxantrone / Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis, Relapsing-Remitting / Topoisomerase II Inhibitors Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur J Neurol Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mitoxantrone / Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis, Relapsing-Remitting / Topoisomerase II Inhibitors Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur J Neurol Year: 2018 Document type: Article